| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.8432 | 58 |
| GSM780708 | Untreated after 4 days (C2_1) | 58.3539 | 63 |
| GSM780709 | Untreated after 4 days (C3_1) | 57.9631 | 63 |
| GSM780719 | Untreated after 4 days (C1_2) | 62.6574 | 66 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.201 | 42 |
| GSM780721 | Untreated after 4 days (C3_2) | 52.6624 | 55 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 57.3154 | 62 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 64.0847 | 67 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 70.7551 | 69 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 56.9849 | 62 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 59.4296 | 64 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.49 | 47 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 63.9099 | 67 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 59.6197 | 64 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.5032 | 50 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 61.329 | 65 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 63.8257 | 67 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 63.2939 | 66 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 52.9333 | 56 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 68.3692 | 68 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 62.0881 | 66 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 73.8605 | 70 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 58.895 | 64 |